Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease

Abstract Background: Melatonin (MLT) can improve mitophagy, thereby ameliorating cognitive deficits in Alzheimer’s disease (AD) patients. Hence, our research focused on the potential value of MLT-related genes (MRGs) in AD through bioinformatic analysis. Methods: First, the key cells in the single-c...

Full description

Saved in:
Bibliographic Details
Main Authors: Hua-xiong Zhang, Dilmurat Hamit, Qing Li, Xiao Hu, San-feng Li, Fu Xu, Ming-yuan Wang, Guo-qing Bao, Hong-yan Li
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-80755-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862530190082048
author Hua-xiong Zhang
Dilmurat Hamit
Qing Li
Xiao Hu
San-feng Li
Fu Xu
Ming-yuan Wang
Guo-qing Bao
Hong-yan Li
author_facet Hua-xiong Zhang
Dilmurat Hamit
Qing Li
Xiao Hu
San-feng Li
Fu Xu
Ming-yuan Wang
Guo-qing Bao
Hong-yan Li
author_sort Hua-xiong Zhang
collection DOAJ
description Abstract Background: Melatonin (MLT) can improve mitophagy, thereby ameliorating cognitive deficits in Alzheimer’s disease (AD) patients. Hence, our research focused on the potential value of MLT-related genes (MRGs) in AD through bioinformatic analysis. Methods: First, the key cells in the single-cell dataset GSE138852 were screened out based on the proportion of annotated cells and Fisher’s test between the AD and control groups. The differentially expressed genes (DEGs) in the key cell and GSE5281 datasets were identified, and the MRGs in GSE5281 were selected via weighted gene coexpression network analysis. After intersecting two sets of DEGs and MRGs, we performed Mendelian randomization analysis to identify the MRGs causally related to AD. Biomarkers were further ascertained through receiver operating characteristic curve (ROC) and expression analysis in GSE5281 and GSE48350. Furthermore, gene set enrichment analysis, immune infiltration analysis and correlation analysis with metabolic pathways were conducted, as well as construction of a regulator network and molecular docking. Results: According to the Fisher test, oligodendrocytes were regarded as key cells due to their excellent abundance in the GSE138852 dataset, in which there were 281 DEGs between the AD and control groups. After overlapping with 3,490 DEGs and 550 MRGs in GSE5281, four genes were found to be causally related to AD, namely, G protein-coupled receptor, family C, group 5, member B (GPRC5B), Methyltransferase-like protein 7 A (METTL7A), NF-κB inhibitor alpha (NFKBIA) and RAS association domain family 4(RASSF4). Moreover, GPRC5B, NFKBIA and RASSF4 were deemed biomarkers, except for METTL7A, because of their indistinctive expression between the AD and control groups. Biomarkers might be involved in oxidative phosphorylation, adipogenesis and heme metabolism. Moreover, T helper type 17 cells, natural killer cells and CD56dim natural killer cells were significantly correlated with biomarkers. Transcription factors (GATA2, POU2F2, NFKB1, etc.) can regulate the expression of biomarkers. Finally, we discovered that all biomarkers could bind to MLT with a strong binding energy. Conclusion: Our study identified three novel biomarkers related to MLT for AD, namely, GPRC5B, NFKBIA and RASSF4, providing a novel approach for the investigation and treatment of AD patients.
format Article
id doaj-art-f0d375ddb01e4d21bf9f6413a8cc86c5
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-f0d375ddb01e4d21bf9f6413a8cc86c52025-02-09T12:31:05ZengNature PortfolioScientific Reports2045-23222025-02-0115111810.1038/s41598-024-80755-xIntegrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s diseaseHua-xiong Zhang0Dilmurat Hamit1Qing Li2Xiao Hu3San-feng Li4Fu Xu5Ming-yuan Wang6Guo-qing Bao7Hong-yan Li8Department of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionAbstract Background: Melatonin (MLT) can improve mitophagy, thereby ameliorating cognitive deficits in Alzheimer’s disease (AD) patients. Hence, our research focused on the potential value of MLT-related genes (MRGs) in AD through bioinformatic analysis. Methods: First, the key cells in the single-cell dataset GSE138852 were screened out based on the proportion of annotated cells and Fisher’s test between the AD and control groups. The differentially expressed genes (DEGs) in the key cell and GSE5281 datasets were identified, and the MRGs in GSE5281 were selected via weighted gene coexpression network analysis. After intersecting two sets of DEGs and MRGs, we performed Mendelian randomization analysis to identify the MRGs causally related to AD. Biomarkers were further ascertained through receiver operating characteristic curve (ROC) and expression analysis in GSE5281 and GSE48350. Furthermore, gene set enrichment analysis, immune infiltration analysis and correlation analysis with metabolic pathways were conducted, as well as construction of a regulator network and molecular docking. Results: According to the Fisher test, oligodendrocytes were regarded as key cells due to their excellent abundance in the GSE138852 dataset, in which there were 281 DEGs between the AD and control groups. After overlapping with 3,490 DEGs and 550 MRGs in GSE5281, four genes were found to be causally related to AD, namely, G protein-coupled receptor, family C, group 5, member B (GPRC5B), Methyltransferase-like protein 7 A (METTL7A), NF-κB inhibitor alpha (NFKBIA) and RAS association domain family 4(RASSF4). Moreover, GPRC5B, NFKBIA and RASSF4 were deemed biomarkers, except for METTL7A, because of their indistinctive expression between the AD and control groups. Biomarkers might be involved in oxidative phosphorylation, adipogenesis and heme metabolism. Moreover, T helper type 17 cells, natural killer cells and CD56dim natural killer cells were significantly correlated with biomarkers. Transcription factors (GATA2, POU2F2, NFKB1, etc.) can regulate the expression of biomarkers. Finally, we discovered that all biomarkers could bind to MLT with a strong binding energy. Conclusion: Our study identified three novel biomarkers related to MLT for AD, namely, GPRC5B, NFKBIA and RASSF4, providing a novel approach for the investigation and treatment of AD patients.https://doi.org/10.1038/s41598-024-80755-xAlzheimer’s diseaseMLTMendelian randomizationBiomarkerMolecular docking
spellingShingle Hua-xiong Zhang
Dilmurat Hamit
Qing Li
Xiao Hu
San-feng Li
Fu Xu
Ming-yuan Wang
Guo-qing Bao
Hong-yan Li
Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
Scientific Reports
Alzheimer’s disease
MLT
Mendelian randomization
Biomarker
Molecular docking
title Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
title_full Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
title_fullStr Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
title_full_unstemmed Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
title_short Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
title_sort integrative bioinformatic approach reveals novel melatonin related biomarkers for alzheimer s disease
topic Alzheimer’s disease
MLT
Mendelian randomization
Biomarker
Molecular docking
url https://doi.org/10.1038/s41598-024-80755-x
work_keys_str_mv AT huaxiongzhang integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease
AT dilmurathamit integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease
AT qingli integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease
AT xiaohu integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease
AT sanfengli integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease
AT fuxu integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease
AT mingyuanwang integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease
AT guoqingbao integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease
AT hongyanli integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease